Synta Pharmaceuticals CEO Paul Friedman's 2018 pay jumps 312% to $5.6M

Synta Pharmaceuticals reports 2018 executive compensation

Published: May 15, 2019

Synta Pharmaceuticals reported fiscal year 2018 executive compensation information on May 15, 2019.

In 2018, three executives at Synta Pharmaceuticals received on average a compensation package of $4.4M, a 289% increase compared to previous year.

Average pay of disclosed executives at Synta Pharmaceuticals

Paul A. Friedman, Chief Executive Officer, received $5.6M in total, which increased by 312% compared to 2017. 87.19% of Friedman's compensation, or $4.9M, was in option awards. Friedman also received $304.5K in non-equity incentive plan and $416.7K in salary.

For fiscal year 2018, the median employee pay was $804,000 at Synta Pharmaceuticals. Therefore, the ratio of Paul A. Friedman's pay to the median employee pay was 7 to one.

Rebecca Taub, Chief Medical Officer, received a compensation package of $4.3M, which increased by 298% compared to previous year. 85.93% of the compensation package, or $3.7M, was in option awards.

Marc R. Schneebaum, Chief Financial Officer, earned $3.4M in 2018, a 247% increase compared to previous year.